Back
ProShares UltraPro Short 20+ Year Treasury Vs. Novartis AG Industry Stock Comparison
Buy
77
TTT
ProShares UltraPro Short 20+ Year Treasury
Last Price:
$71.29
Seasonality Move:
8.87%
Buy
71
NVSEF
Novartis AG
Last Price:
$135.53
Seasonality Move:
-4.44%
Buy
77
ProShares UltraPro Short 20+ Year Treasury (TTT)
is a Buy
Is ProShares UltraPro Short 20+ Year Treasury a Buy, Sell or Hold?
-
The current ProShares UltraPro Short 20+ Year Treasury [TTT] share price is $70.89. The Score for TTT is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
TTT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $138.80. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TTT Stock Price Chart
What is ProShares UltraPro Short 20+ Year Treasury's stock price today?
-
The ProShares UltraPro Short 20+ Year Treasury share price today is $70.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TTT is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $138.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
TTT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 59.7 | Buy |
| Chaikin Money Flow: | -2508 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 69.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.8 - 131.54) | Buy |
| Bollinger Bands (100): | (119.63 - 130.75) | Buy |
TTT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.84 | Buy |
| 20-day SMA: | 68.84 | Buy |
| 50-day SMA: | 66.89 | Buy |
| 200-day SMA: | 72.26 | Sell |
| 8-day EMA: | 70.63 | Buy |
| 20-day EMA: | 69.28 | Buy |
| 50-day EMA: | 66.93 | Buy |
| 200-day EMA: | 42.97 | Buy |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.44 | Buy |
| 20-day SMA: | 127.9 | Buy |
| 50-day SMA: | 128.04 | Buy |
| 200-day SMA: | 119.05 | Buy |
| 8-day EMA: | 129.81 | Buy |
| 20-day EMA: | 128.39 | Buy |
| 50-day EMA: | 127.3 | Buy |
| 200-day EMA: | 120.27 | Buy |
ProShares UltraPro Short 20+ Year Treasury Earnings Growth & TTT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraPro Short 20+ Year Treasury Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||